ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 62 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $28,000 | -24.3% | 4,773 | -1.0% | 0.00% | – |
| Q3 2019 | $37,000 | +37.0% | 4,823 | +148.5% | 0.00% | – |
| Q2 2019 | $27,000 | +350.0% | 1,941 | +88.3% | 0.00% | – |
| Q1 2019 | $6,000 | +100.0% | 1,031 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -62.5% | 1,031 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | -20.0% | 1,031 | 0.0% | 0.00% | – |
| Q2 2018 | $10,000 | +11.1% | 1,031 | 0.0% | 0.00% | – |
| Q1 2018 | $9,000 | -30.8% | 1,031 | 0.0% | 0.00% | – |
| Q4 2017 | $13,000 | +116.7% | 1,031 | +41.0% | 0.00% | – |
| Q3 2017 | $6,000 | -57.1% | 731 | -9.9% | 0.00% | – |
| Q2 2017 | $14,000 | -44.0% | 811 | -34.1% | 0.00% | -100.0% |
| Q1 2017 | $25,000 | +127.3% | 1,231 | +68.4% | 0.00% | – |
| Q4 2016 | $11,000 | – | 731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 507,191 | $5,107,000 | 0.50% |
| Cormorant Asset Management, LP | 356,600 | $3,591,000 | 0.43% |
| Perceptive Advisors | 558,446 | $5,623,000 | 0.42% |
| NEXTHERA CAPITAL LP | 15,000 | $151,000 | 0.21% |
| EMERALD ADVISERS, LLC | 237,070 | $2,387,000 | 0.11% |
| AUXIER ASSET MANAGEMENT | 17,857 | $180,000 | 0.04% |
| FEDERATED HERMES, INC. | 450,000 | $4,532,000 | 0.01% |
| Nationwide Fund Advisors | 49,473 | $498,000 | 0.00% |
| Catalyst Capital Advisors LLC | 348 | $4,000 | 0.00% |
| DEUTSCHE BANK AG\ | 859 | $8,000 | 0.00% |